Drugs / Protein C Concentrate (Human)

Trials 1

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT00157118 Aug 2003 → Mar 2005 hereditary thrombophilia due to congenital protein C deficiency Baxalta now part of Shire Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Protein C Concentrate (Human) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00157118 ↗
Known as Ceprotin ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Human protein c ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protein c ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protein c (coagulation inhibitor) ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protein c (homo sapiens) ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protein c component of balfaxar ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protein c human ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Known as Protexel ChEMBL registry synonym — accepted as the source's own label CHEMBL5315087 ↗
Modality Protein / enzyme biologic “Protein C Concentrate (Human) Vapor Heated” NCT00157118 ↗
Target PROC “Vitamin K-dependent protein C exogenous protein” CHEMBL5315087 ↗